Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
NCT00751608 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2016-09-23
Summary
This study will evaluate the effect of APL180 on endothelial function measured by forearm venous occlusion plethysmography in patients with familial hypercholesterolemia.
Conditions
- Familial Hypercholesterolemia
Interventions
- DRUG
-
APL180
- DRUG
-
APL180
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis · Novartis Investigator Site
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
More Related Trials
-
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
NCT01715818 ·Status: COMPLETED ·Phase: PHASE3
-
Aliskiren Effect on Aortic Plaque Progression
NCT01417104 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
NCT00185263 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
NCT01499420 ·Status: COMPLETED ·Phase: PHASE2
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)
NCT03626662 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
NCT02257294 ·Status: COMPLETED ·Phase: PHASE2
-
A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848
NCT00743860 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease
NCT01157156 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
NCT03872401 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
NCT03297814 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins
NCT00377806 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
NCT01711723 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients
NCT00734032 ·Status: COMPLETED ·Phase: PHASE2
-
NK-1 Antagonism of SLV317 in Humans
NCT00160862 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)
NCT05618691 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
NCT05646381 ·Status: RECRUITING ·Phase: PHASE2
-
The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina
NCT01763996 ·Status: COMPLETED ·Phase: PHASE4
-
A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).
NCT00760565 ·Status: COMPLETED ·Phase: PHASE1
-
The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial
NCT03542110 ·Status: TERMINATED ·Phase: PHASE4
-
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
NCT01813422 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)
NCT00679055 ·Status: TERMINATED ·Phase: PHASE1
-
Carotid Plaque Screening Trial in Smokers
NCT00548665 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries
NCT00115999 ·Status: COMPLETED ·Phase: PHASE3